What does CUSIP 004225108 represent in this 13F holders report?

CUSIP 004225108 is the security identifier for ACAD - ACADIA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in Q4 2020?

298 institutional investors reported ACAD - ACADIA PHARMACEUTICALS INC - Common Stock for Q4 2020. Use the holders table for investor-level position and value details.

ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock
Shares outstanding: 170,504,990
Total 13F shares: 147,844,682
Share change: -2,296,885
Total reported value: $7,903,754,877
Put/Call ratio: 64%
Price per share: $53.46
Number of holders: 298
Value change: -$103,617,443
Number of buys: 150
Number of sells: 123

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 004225108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	25%	41,904,586	$1,728,564,000	—	30 Sep 2020	13F
FMR LLC	13F	Company	12%	19,748,348	$814,619,000	—	30 Sep 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	6.2%	10,537,138	$434,657,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	6.1%	10,369,690	$427,750,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	4.2%	7,161,211	$295,400,000	—	30 Sep 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.3%	5,706,104	$235,378,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	1.6%	2,702,584	$111,482,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.5%	2,569,751	$106,003,000	—	30 Sep 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1.3%	2,264,513	$93,411,000	—	30 Sep 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	1.3%	2,235,863	$92,229,000	—	30 Sep 2020	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	1.2%	2,078,148	$85,724,000	—	30 Sep 2020	13F
GREAT POINT PARTNERS LLC	13F	Company	1.1%	1,921,563	$79,264,000	—	30 Sep 2020	13F
Palo Alto Investors LP	13F	Company	1.1%	1,832,300	$75,582,000	—	30 Sep 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	1%	1,717,131	$70,832,000	—	30 Sep 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.93%	1,582,279	$65,269,000	—	30 Sep 2020	13F
Rock Springs Capital Management LP	13F	Company	0.92%	1,573,200	$64,895,000	—	30 Sep 2020	13F
NORGES BANK	13F	Company	0.79%	1,353,618	$55,837,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.78%	1,330,316	$54,875,000	—	30 Sep 2020	13F
Marshall Wace North America L.P.	13F	Company	0.72%	1,219,189	$50,292,000	—	30 Sep 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.71%	1,216,007	$50,160,000	—	30 Sep 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.71%	1,205,846	$49,741,000	—	30 Sep 2020	13F
MARSHALL WACE, LLP	13F	Company	0.66%	1,133,812	$46,769,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.6%	1,018,120	$41,998,000	—	30 Sep 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.58%	996,942	$41,124,000	—	30 Sep 2020	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.58%	994,039	$41,004,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	960,067	$39,603,000	—	30 Sep 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	895,547	$36,942,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.51%	869,842	$35,149,000	—	30 Sep 2020	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.45%	775,152	$31,975,000	—	30 Sep 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.42%	709,805	$29,280,000	—	30 Sep 2020	13F
SAMLYN CAPITAL, LLC	13F	Company	0.4%	680,194	$28,059,000	—	30 Sep 2020	13F
Fairmount Funds Management LLC	13F	Company	0.38%	647,833	$26,723,000	—	30 Sep 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.37%	638,200	$26,326,000	—	30 Sep 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.35%	591,532	$24,401,000	—	30 Sep 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.35%	589,726	$24,326,198	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.34%	587,883	$24,250,000	—	30 Sep 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.34%	578,195	$23,851,000	—	30 Sep 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.33%	556,514	$22,956,000	—	30 Sep 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.29%	492,430	$20,313,000	—	30 Sep 2020	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.29%	486,000	$20,048,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.28%	485,638	$20,032,000	—	30 Sep 2020	13F
Hood River Capital Management LLC	13F	Company	0.25%	422,765	$17,439,000	—	30 Sep 2020	13F
PFM Health Sciences, LP	13F	Company	0.25%	421,087	$17,370,000	—	30 Sep 2020	13F
Bank of New York Mellon Corp	13F	Company	0.24%	409,327	$16,884,000	—	30 Sep 2020	13F
Allianz Asset Management GmbH	13F	Company	0.23%	389,377	$16,062,000	—	30 Sep 2020	13F
Neuberger Berman Group LLC	13F	Company	0.22%	378,100	$15,597,000	—	30 Sep 2020	13F
Boxer Capital, LLC	13F	Company	0.22%	370,000	$15,263,000	—	30 Sep 2020	13F
Woodline Partners LP	13F	Company	0.19%	327,415	$13,506,000	—	30 Sep 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.19%	327,217	$13,493,000	—	30 Sep 2020	13F
S.c.a. Candriam	13F	Individual	0.18%	309,000	$12,746,000	—	30 Sep 2020	13F

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q4 2020

As of 31 Dec 2020, ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by 298 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 147,844,682 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, Palo Alto Investors LP, and D. E. Shaw & Co., Inc.. This page lists 299 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

262

Q4 2020 holders

298

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.